These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 20660383
41. 5-[I-125/123]lodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors. Musachio JL, Scheffel U, Finley PA, Zhan Y, Mochizuki T, Wagner HN, Dannals RF. Life Sci; 1998; 62(22):PL 351-7. PubMed ID: 9627107 [Abstract] [Full Text] [Related]
42. beta2 Nicotinic acetylcholine receptor availability in post-traumatic stress disorder. Czermak C, Staley JK, Kasserman S, Bois F, Young T, Henry S, Tamagnan GD, Seibyl JP, Krystal JH, Neumeister A. Int J Neuropsychopharmacol; 2008 May; 11(3):419-24. PubMed ID: 18190729 [Abstract] [Full Text] [Related]
43. Quantification of alpha4beta2* nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380. Vaupel DB, Stein EA, Mukhin AG. Neuroimage; 2007 Feb 15; 34(4):1352-62. PubMed ID: 17187994 [Abstract] [Full Text] [Related]
46. In vivo relationship between thalamic nicotinic acetylcholine receptor occupancy rates and antiallodynic effects in a rat model of neuropathic pain: persistent agonist binding inhibits the expression of antiallodynic effects. Ueda M, Iida Y, Yoneyama T, Kawai T, Ogawa M, Magata Y, Saji H. Synapse; 2011 Jan 15; 65(1):77-83. PubMed ID: 20506320 [Abstract] [Full Text] [Related]
48. Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain. Hillmer AT, Esterlis I, Gallezot JD, Bois F, Zheng MQ, Nabulsi N, Lin SF, Papke RL, Huang Y, Sabri O, Carson RE, Cosgrove KP. Neuroimage; 2016 Nov 01; 141():71-80. PubMed ID: 27426839 [Abstract] [Full Text] [Related]
49. 5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects. Ueda M, Iida Y, Mukai T, Mamede M, Ishizu K, Ogawa M, Magata Y, Konishi J, Saji H. Ann Nucl Med; 2004 Jun 01; 18(4):337-44. PubMed ID: 15359928 [Abstract] [Full Text] [Related]
54. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers. DeVeaugh-Geiss AM, Chen LH, Kotler ML, Ramsay LR, Durcan MJ. Clin Ther; 2010 Jun 01; 32(6):1140-8. PubMed ID: 20637967 [Abstract] [Full Text] [Related]
55. Smoking-induced ventral striatum dopamine release. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA. Am J Psychiatry; 2004 Jul 01; 161(7):1211-8. PubMed ID: 15229053 [Abstract] [Full Text] [Related]
57. Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors. Anderson SM, Brunzell DH. Br J Pharmacol; 2015 Jun 01; 172(11):2864-77. PubMed ID: 25625469 [Abstract] [Full Text] [Related]
58. [125/123I]IPH: a radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors. Musachio JL, Villemagne VL, Scheffel U, Stathis M, Finley P, Horti A, London ED, Dannals RF. Synapse; 1997 Aug 01; 26(4):392-9. PubMed ID: 9215598 [Abstract] [Full Text] [Related]
59. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine. Mugnaini M, Garzotti M, Sartori I, Pilla M, Repeto P, Heidbreder CA, Tessari M. Neuroscience; 2006 Aug 01; 137(2):565-72. PubMed ID: 16289885 [Abstract] [Full Text] [Related]